XML 66 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2014
Stockholders' Equity  
Schedule of changes in stockholders' equity

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Stockholders’

 

 

 

Common Stock

 

Additional Paid-

 

Comprehensive

 

Treasury Stock

 

Accumulated

 

(Deficit)

 

 

 

Shares

 

Amount

 

in-Capital

 

Income

 

Shares

 

Amount

 

Deficit

 

Equity

 

December 31, 2013

 

106,356,558

 

$

1,063,566

 

$

831,155,925

 

$

897,807

 

165,906

 

$

(1,552,382

)

$

(849,437,066

)

$

(17,872,150

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to the Company

 

 

 

 

 

 

 

(81,331,176

)

(81,331,176

)

Stock based compensation

 

106,813

 

1,069

 

2,366,182

 

 

 

 

 

2,367,251

 

Public offerings, common stock, net (1) 

 

36,502,440

 

365,024

 

153,584,354

 

 

 

 

 

153,949,378

 

Exercise of warrants (2) 

 

23,918,429

 

239,184

 

101,886,304

 

 

86,391

 

(340,381

)

 

101,785,107

 

Stock dividend

 

25,348

 

253

 

129,595

 

 

 

 

(129,848

)

 

Shares issued for acquisition

 

530,504

 

5,305

 

3,994,695

 

 

 

 

 

4,000,000

 

Conversion of preferred stock

 

5,521,676

 

55,217

 

1,163,143

 

 

 

 

 

1,218,360

 

Stock option exercises

 

518,845

 

5,188

 

400,613

 

 

109,930

 

(678,863

)

 

(273,062

)

September 30, 2014

 

173,480,613

 

$

1,734,806

 

$

1,094,680,811

 

$

897,807

 

362,227

 

$

(2,571,626

)

$

(930,898,090

)

$

163,843,708

 

 

 

(1)       As a result of the January, March and April 2014 public offerings discussed further below, the Company received net proceeds of $165,722,618 of which $11,773,240 in value was ascribed to the warrants issued in the January 2014 public offering. The associated warrants have been separately valued and classified as a liability on the accompanying consolidated balance sheet.

 

(2)       Pursuant to the exercise of warrants, additional paid-in capital was increased by $18,102,213 from the issuance of 23,832,038 shares of common stock. Additionally, paid-in capital was increased by $83,444,573 and warrant liability was reduced by $83,444,573 (the fair value of the warrants on the exercise date).